来自Caulobacter crescentus的外膜囊泡:用于重组抗原呈现的平台
Luis David Ginez1, Aurora Osorio1, Víctor Correal-Medina1
1Departamento de Biología Molecular y Biotecnologia, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Instituto de Investigaciones Biomédicas, Circuito Mario de la Cueva s/n, Ciudad Universitaria, Ciudad de México 04510, México.
来自Caulobacter crescentus的细菌外膜囊泡 (OMV) 提供了一个安全有效的疫苗平台. 这些OMV显示炎症减少,并可以呈现抗原,使低成本的疫苗开发.
科学领域:
- 生物技术是生物技术.
- 疫苗学 疫苗学 疫苗学
- 微生物学 微生物学
背景情况:
- 细菌外膜囊泡 (OMVs) 是有前途的疫苗候选人,因为它们的辅助性质,大小,非细胞性和成本效益.
- 然而,OMVs可以引起严重的炎症反应,并且产量低,限制了它们的疫苗应用.
研究的目的:
- 为了改造Caulobacter crescentus,提高OMV的生产能力.
- 评估C. crescentus衍生OMVs作为疫苗平台的安全性和有效性,与Escherichia coli K-12OMVs相比.
主要方法:
- 工程设计的C. crescentus用于高OMV产量.
- 在小鼠模型和人类细胞测定中评估了OMV的炎症潜力.
- 装载有重组蛋白质的OMV,并评估了体内免疫性.
主要成果:
- 经过工程改造的C. crescentus菌株显示出高的OMV产量.
- C. crescentus OMV 诱导的炎症反应明显低于 E. coli K-12 OMV.
- OMV有效地呈现了重组抗原,引起了具有辅助作用的抗体产生.
结论:
- C. crescentus OMVs 代表了疫苗开发的安全有效平台.
- 这种方法有助于创建具有减少炎症潜力的低成本疫苗.
更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
相关概念视频
Intralumenal Vesicles and Multivesicular Bodies
Clathrin Coated Vesicles
Vesicular Tubular Clusters
With the help of motor proteins such...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
